関連する実験動画
Updated: Feb 28, 2026

07:51
Isolation of Leukocytes from the Murine Tissues at the Maternal-Fetal Interface
Published on: May 21, 2015
18.1K
人間の胎児のデンドリト細胞は,アルギナース2による胎児前T細胞の免疫抑制を促進する
Naomi McGovern1, Amanda Shin1,2, Gillian Low1
1Singapore Immunology Network (SIgN), A*STAR, 8A Biomedical Grove, Immunos Building, Level 3 and 4, Singapore 138648, Singapore.
Nature
|June 15, 2017
まとめ
免疫に不可欠な胎児の dendritic 細胞は,十分に理解されていなかった. この研究は 細胞が移動し 刺激に反応し 妊娠中にT細胞の反応を抑制することで 免疫耐性を促進することを示しています
科学分野:
- 免疫学
- 発達生物学
- 胎児 の 発達
背景:
- 発達中の胎児は 免疫を刺激する分子に遭遇しますが 免疫系の反応能力は不明です
- 免疫と耐性のために不可欠なデンドリティック細胞 (DCs) は胎児の発達に欠けています.
研究 の 目的:
- 胎児の dendritic 細胞と妊娠中の免疫反応におけるその機能を特徴付ける.
- 胎児のDCsが免疫耐性を媒介する役割を調査する.
主な方法:
- 胎児組織における抗原を提示する細胞サブセットの識別と特徴付け.
- リンパ節への胎児の dendritic 細胞の移動の分析
- 胎児の dendritic 細胞のトール型受容体結合と全遺伝的抗原に対する反応の評価.
主要な成果:
- 成人集団に関連した胎児の抗原呈現細胞と樹状細胞が特定されました.
- 胎児の dendritic 細胞はリンパ節に移動し,トールのような受容体結合に反応する.
- 胎児の dendritic 細胞は,T細胞の調節誘導を促進し,アルギナーゼ2経由でT細胞のTNF-α産生を抑制し,成人のDCと異なったアロゲン反応を示します.
結論:
- 胎児の dendritic 細胞は,妊娠中の免疫調節に重要な役割を果たします.
- これらの細胞はホメオスタティックな免疫抑制反応を媒介し,胎児の耐性に貢献します.
関連する概念動画
Development of Immunocompetence
1.0K
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.0K
Teratogenicity
4.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.4K
Transcytosis of IgG
4.3K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
4.3K

